Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Insights and Analysis
18 April 2024
The Digital Markets Act provides not only compliance duties, but also opportunities for those seeking to enforce their rights under the DMA. Be it enhancing interoperability or opening up...
Insights and Analysis
05 April 2024
Offering an alternative between payment and advertising is not per se contrary to the freedom of consent under the GDPR.
News
05 April 2024
With the recent filing of an amicus brief in a private pharmaceutical patent infringement case, the Federal Trade Commission (FTC) has continued its focus on allegedly “improperly...
News
02 April 2024
The European Commission has opened a formal investigation into whether Zoetis, a US animal health company, has acted in breach of the abuse of dominance rules by terminating development of...
News
22 March 2024
In a ruling with significant implications for companies facing sham-litigation claims, such as those that can arise in the Hatch-Waxman context for pharmaceutical manufacturers, the Third...
Media Mention
14 March 2024
M&A slowed in 2023, but deals are still getting done. In the latest episode of The Pipeline podcast, Global Head of M&A Bill Curtin dissects the challenges and adaptive strategies...
News
14 March 2024
The EU AI Act is on the verge of becoming the first law to specifically govern the use of artificial intelligence at a European level. In light of the extensive set of new obligations...
News
13 March 2024
Private equity investment in the health care sector continues to be a significant area of focus for the U.S. antitrust agencies. On March 5, 2024, the Federal Trade Commission (FTC)...
News
04 March 2024
On January 26, 2024 the Federal Trade Commission (“FTC”) and Department of Justice (“DOJ”) announced1 that the standard preservation letters and specifications...
